PubRank

Zhaohui Su

Author PubWeight™ 38.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211. J Infect Dis 2007 3.75
2 Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PLoS One 2009 3.40
3 HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211. Clin Infect Dis 2007 3.05
4 Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. J Infect Dis 2007 2.05
5 In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject. J Virol 2008 1.84
6 Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. Clin Infect Dis 2008 1.66
7 Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study. Drug Alcohol Depend 2006 1.44
8 A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients. PLoS One 2012 1.18
9 Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity. Clin Infect Dis 2011 1.14
10 Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients. J Acquir Immune Defic Syndr 2010 1.04
11 Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211. Clin Infect Dis 2009 0.96
12 Probing reward function in posttraumatic stress disorder: expectancy and satisfaction with monetary gains and losses. J Psychiatr Res 2008 0.92
13 Polyelectrolyte-multilayer-supported Au@Ag core-shell nanoparticles with high catalytic activity. Adv Mater 2012 0.91
14 Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. AIDS 2010 0.86
15 Pulling genetic RNA out of tobacco mosaic virus using single-molecule force spectroscopy. J Am Chem Soc 2010 0.86
16 Surface modification of poly(L-lactic acid) to improve its cytocompatibility via assembly of polyelectrolytes and gelatin. Acta Biomater 2005 0.85
17 Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions. J Clin Microbiol 2009 0.85
18 CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway. AIDS Res Hum Retroviruses 2008 0.84
19 A standardized kudzu extract (NPI-031) reduces alcohol consumption in nontreatment-seeking male heavy drinkers. Psychopharmacology (Berl) 2012 0.83
20 Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170. J Acquir Immune Defic Syndr 2008 0.82
21 Covalently attached, silver-doped poly(vinyl alcohol) hydrogel films on poly(l-lactic acid). Biomacromolecules 2010 0.81
22 Tunable wettability and rewritable wettability gradient from superhydrophilicity to superhydrophobicity. Langmuir 2010 0.81
23 Synthesis of hollow Ag-Au bimetallic nanoparticles in polyelectrolyte multilayers. Langmuir 2013 0.80
24 Incorporation of nanoparticles into polyelectrolyte multilayers via counterion exchange and in situ reduction. Langmuir 2009 0.80
25 Benztropine pretreatment does not affect responses to acute cocaine administration in human volunteers. Hum Psychopharmacol 2006 0.79
26 Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures. J Virol 2012 0.79
27 Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170). AIDS 2012 0.78
28 Self-assembly of virus particles on flat surfaces via controlled evaporation. Langmuir 2010 0.77
29 Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211). J Acquir Immune Defic Syndr 2010 0.77
30 Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170). AIDS 2012 0.77
31 Health information wanted and obtained from doctors/nurses: a comparison of Chinese cancer patients and family caregivers. Support Care Cancer 2015 0.77
32 Layer-by-layer assembly of single-charged ions with a rigid polyampholyte. Chem Commun (Camb) 2008 0.76
33 Facile synthesis of AuPt alloy nanoparticles in polyelectrolyte multilayers with enhanced catalytic activity for reduction of 4-nitrophenol. Langmuir 2014 0.76
34 A surface with superoleophilic-to-superoleophobic wettability gradient. ACS Appl Mater Interfaces 2014 0.75
35 Scanning tunneling microscopy investigation of self-assembled poly(3-hexylthiophene) monolayer. J Chem Phys 2013 0.75
36 Orientation of syndiotactic polystyrene crystallized in cylindrical nanopores. Macromol Rapid Commun 2008 0.75
37 Controlled evaporative self-assembly of poly(3-hexylthiophene) monitored with confocal polarized Raman spectroscopy. Phys Chem Chem Phys 2012 0.75
38 Poly(2-vinylpyridine)-block -Poly(ϵ-caprolactone) single crystals in micellar solution. Macromol Rapid Commun 2013 0.75
39 Infrared imaging of ring-banded spherulites formed in poly(L-lactide)-poly(ethylene glycol) diblock copolymer: segment distribution and orientation. Appl Spectrosc 2011 0.75
40 Technology-Based Interventions for Nursing Home Residents: Implications for Nursing Home Practice Amid and Beyond the Influence of COVID-19: A Systematic Review Protocol. Res Sq 2020 0.75
41 Spectroscopic study on water diffusion in poly(ester urethane) block copolymer matrix. J Phys Chem B 2009 0.75
42 Controlled assembly of protein in glass capillary. Langmuir 2010 0.75
43 Upconversion luminescence properties of Er(3+)-Bi3+ codoped CaSnO3 nanocrystals with perovskite structure. J Nanosci Nanotechnol 2010 0.75
44 A surface exhibiting superoleophobicity both in air and in seawater. ACS Appl Mater Interfaces 2013 0.75
45 Ionic liquids as plasticizers for polyelectrolyte complexes. J Phys Chem B 2015 0.75
46 Fabrication of surfaces with extremely high contact angle hysteresis from polyelectrolyte multilayer. Langmuir 2011 0.75
47 Tunable wettability by counterion exchange at the surface of electrostatic self-assembled multilayers. Chem Commun (Camb) 2008 0.75
48 Coarsening of silver nanoparticles in polyelectrolyte multilayers. Langmuir 2013 0.75
49 Fabrication of Au@Ag core-shell nanoparticles using polyelectrolyte multilayers as nanoreactors. Langmuir 2012 0.75
50 Ordering of poly(3-hexylthiophene) in solution and on substrates induced by concentrated sulfuric acid. J Phys Chem B 2013 0.75